The advanced therapeutics pharmaceutical outsourcing market is projected to reach $10.73 billion by 2030 at a 5.0% CAGR, driven by cell & gene therapy outsourcing and CDMO expansion.
Read More
The adult vaccines market is projected to reach $37.51 billion by 2030 at a 9.2% CAGR, driven by mRNA advancements, immunization programs, and growing vaccine awareness.
Read More
The adrenoleukodystrophy drugs market is set to reach $1.13 billion by 2030 at a 10.3% CAGR, driven by gene therapy, orphan drug incentives, and early diagnosis programs.
Read More
The Adhatoda Vasica extract market is projected to reach $1.98 billion by 2030 at an 8.9% CAGR, driven by herbal respiratory remedies, ayurvedic products, and phytochemical research.
Read More
The adenosine market is set for rapid growth, reaching $1.83 billion by 2030 at a 10.9% CAGR, driven by cardiovascular use, oncology research, and biotech advances.
Read More
The AAV vectors in gene therapy market is poised for rapid growth, reaching $6.99 billion by 2030 at a 17.2% CAGR, driven by gene therapy launches and scalable vector manufacturing.
Read More
The adalimumab, infliximab, and etanercept biosimilars market is set for rapid growth, reaching $8.05 billion by 2030 at a 10.1% CAGR, driven by cost-effective TNF-alpha therapies.
Read More
The acute ischemic stroke drugs market is projected to reach $18.86 billion by 2030 at a 6.2% CAGR, driven by neuroprotective advances, AI diagnostics, and personalized therapy.
Read More
The acute intermittent porphyria market is expected to reach $6.33 billion by 2030 at a 6.2% CAGR, driven by novel therapies, genetic diagnostics, and telemedicine adoption.
Read More
The active pharmaceutical ingredients market is set for strong growth, reaching $341.32 billion by 2030 at a 7.0% CAGR, driven by biologics, precision medicine, and contract manufacturing.
Read More